Browse > Article
http://dx.doi.org/10.5292/jkbjts.2010.16.2.69

The Significance of Sentinel Node Biopsy in Malignant Melanoma and Squamous Cell Carcinoma of Lower Extremities  

Kim, Jae-Do (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
Lee, Gun-Woo (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
Kwon, Young-Ho (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
Chung, So-Hak (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
Publication Information
The Journal of the Korean bone and joint tumor society / v.16, no.2, 2010 , pp. 69-73 More about this Journal
Abstract
Purpose: Sentinel lymph node (SLNB) is the first confronted lymph node from primary lesion of tumor through lymphatic drainage, which is important for determining early metastasis and setting guidelines for treatment. We reported significant of sentinel lymph node biopsy in malignant melanoma (MM) and squamous cell carcinoma (SCC) of lower extremities. Materials and Methods: Twenty-five cases of surgically treatment and being possible for follow up more than 1 year among the patients who were diagnosed as MM and SCC in this institution from Sep. 2005 to Jan. 2009, and 10 cases of them were performed SLNB. Average age was 64 years old, and 15 cases of male and 10 cases of female were in this group. Results: 3 years overall survival rate was 100% and 3 years disease-free survival rate was 76%. Metastasis occurred in total 6 patients, 4 cases of inguinal lymph nodes, 1 case of soft tissue around knee, 1 case of left achilles tendon. In 15 cases of not performing SLNB, overall survival rate was 93.3% and disease-free survival rate was 73.3%. In 10 cases of performing SLNB, overall survival rate was 100% and disease-free survival rate was 90%. And only 1 case showed positive finding in the biopsy, and none of the 10 cases showed metastasis in follow-up. Conclusion: SLNB leads simpler and less complications compared to prior elective lymph node dissection, and shows high degree of accuracy. Throughout the SLNB, setting guidelines for treatment by accurate staging is thought to be helpful for increasing the survival rate in the patient with MM and SCC.
Keywords
malignant melanoma (MM); squamous cell carcinoma (SCC); sentinel lymph node biopsy (SLNB);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-30.   DOI   ScienceOn
2 Uren RF, Howman-Giles RB, Thompson JF. Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy. Ann Surg Oncol. 1998;5:517-21.   DOI   ScienceOn
3 Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg. 2005;242:133-42.   DOI   ScienceOn
4 Robinson DS, Sample WF, Fee HJ, et al. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum. 1977;28:147-8.
5 Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-90.
6 Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identify of sentinel lymph nodes in cutaneous melanoma. Cancer. 2001;92:535-41.   DOI   ScienceOn
7 Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol. 2007;33:364-9.   DOI   ScienceOn
8 Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.   DOI   ScienceOn
9 Kwon YH, Kim JR, Lee YG, Kim JD. Analysis of treatment and prognosis in malignant melanoma. J Korean Bone & Joint Tumor Soc. 2005;11:141-7.
10 Cochran AJ, Essner R, Ross DM, et al. Principle of sentinel lymph node identification: background and clinical implications. Langenbeck's Arch Surg. 2000;385:252-60.   DOI   ScienceOn
11 Balch CM, Milton GW, Cascinelli N, et al. Elective lymph node dissection: pros and cons. Cutaneous melanoma. 2nd ed. Philadelphia: Lippincott; 1992. 345-66.
12 Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of Stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61:697-705.   DOI   ScienceOn
13 Chen SL, Iddings DM, Scheri RP, et al. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56:292-309.   DOI   ScienceOn
14 Roka F, Kittler H, Cauzig P, et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivatiate analysis. Br J Cancer. 2005;92:662-7.   DOI   ScienceOn
15 Thompson JF, Uren RF. Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit. Semin Oncol. 2004;31:349-56.   DOI   ScienceOn
16 Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med. 2001;344:975-83.   DOI   ScienceOn
17 Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamaous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32:1309-21.   DOI   ScienceOn
18 McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543-7.   DOI   ScienceOn
19 Morton DL, Cagle L, Wong J. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. Presented at the 42nd Annual Meeting of the Society of Surgical Oncology, Washington DC; 1990.
20 Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical consideration of the procedure as performed at the John Wayne Cancer institute. J Surg Oncol. 2010;101:669-76.   DOI   ScienceOn